LIU JEAN I — SEC insider filings
SEC reporting owner CIK 1241357. 47 insider filings on record with FilingPulse; latest filed 2026-10-01.
Transaction summary — filings shown
Covers all 47 filings on record, filed 2020-08-17 to 2026-10-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 38 legs across 24 filings — 114,818 shares, $19,349,104 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 93.
- Largest priced transaction: sale of 14,457 shares @ $178.07 ($2,574,358) in Seagen Inc., filed 2021-11-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Seagen Inc. (SGEN) | Chief Legal Officer | 36 | — | 38 legs · 114,818 sh · $19,349,104 | 82 |
| Erasca, Inc. (ERAS) | Director | 8 | — | — | 8 |
| Connect Biopharma Holdings Ltd (CNTB) | Director | 3 | — | — | 3 |
Insider filings — LIU JEAN I
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-01 | 4 | Connect Biopharma Holdings Ltd (CNTB) | Grant/award (A): 8,984 @ $0 | EDGAR |
| 2026-07-01 | 4 | Connect Biopharma Holdings Ltd (CNTB) | Grant/award (A): 6,718 @ $0 | EDGAR |
| 2026-06-29 | 4 | Erasca, Inc. (ERAS) | Grant/award (A): 29,888 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | Connect Biopharma Holdings Ltd (CNTB) | Grant/award (A): 5,061 @ $0 | EDGAR |
| 2026-01-05 | 4 | Erasca, Inc. (ERAS) | Grant/award (A): 20,617 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Erasca, Inc. (ERAS) | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2025-01-02 | 4 | Erasca, Inc. (ERAS) | Grant/award (A): 24,939 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Erasca, Inc. (ERAS) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-01-03 | 4 | Erasca, Inc. (ERAS) | Grant/award (A): 35,482 (derivative) @ $0 | EDGAR |
| 2023-12-15 | 4 | Seagen Inc. (SGEN) | Disposition to issuer (D): 48,748 @ $229 · Disposition to issuer (D): 7,446 (derivative) · Disposition to issuer (D): 35,293 (derivative) · Disposition to issuer (D): 40,344 (derivative) · Disposition to issuer (D): 40,523 (derivative) · Disposition to issuer (D): 1,333 (derivative) · +23 more | EDGAR |
| 2023-09-22 | 4 | Seagen Inc. (SGEN) | Sale (S): 64 @ $206.50 | EDGAR |
| 2023-09-01 | 4 | Seagen Inc. (SGEN) | Sale (S): 1,893 @ $206.97 | EDGAR |
| 2023-08-30 | 4 | Seagen Inc. (SGEN) | Grant/award (A): 1,022 @ $0 · Sale (S): 405 @ $206 | EDGAR |
| 2023-08-17 | 4 | Seagen Inc. (SGEN) | Grant/award (A): 13,107 @ $0 · Disposition to issuer (D): 717 @ $193.87 · Disposition to issuer (D): 922 @ $193.87 · Disposition to issuer (D): 1,369 @ $193.87 | EDGAR |
| 2023-08-09 | 4 | Seagen Inc. (SGEN) | Gift (G): 11,124 @ $0 | EDGAR |
| 2023-06-26 | 4 | Erasca, Inc. (ERAS) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2023-04-19 | 4 | Seagen Inc. (SGEN) | Option exercise (M): 5,000 @ $39.15 · Sale (S): 5,000 @ $205.86 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2023-04-12 | 4/A | Seagen Inc. (SGEN) | Holdings only — no transactions reported | EDGAR |
| 2023-04-07 | 4 | Seagen Inc. (SGEN) | Grant/award (A): 435 @ $0 · Sale (S): 174 @ $205.86 | EDGAR |
| 2023-04-04 | 4 | Seagen Inc. (SGEN) | Grant/award (A): 1,389 @ $0 | EDGAR |
| 2023-03-17 | 4 | Seagen Inc. (SGEN) | Option exercise (M): 5,000 @ $39.15 · Sale (S): 5,000 @ $199.90 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2023-02-21 | 4 | Seagen Inc. (SGEN) | Option exercise (M): 5,000 @ $39.15 · Sale (S): 5,000 @ $155 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2023-01-26 | 4 | Seagen Inc. (SGEN) | Option exercise (M): 5,000 @ $39.15 · Sale (S): 5,000 @ $135.03 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2023-01-19 | 4 | Seagen Inc. (SGEN) | Sale (S): 578 @ $130.71 | EDGAR |
| 2023-01-06 | 4 | Seagen Inc. (SGEN) | Option exercise (M): 475 @ $39.15 · Sale (S): 475 @ $135 · Option exercise (M): 4,525 @ $39.15 · Sale (S): 4,525 @ $135 · Option exercise (M): 475 (derivative) @ $0 · Option exercise (M): 4,525 (derivative) @ $0 | EDGAR |
| 2022-11-18 | 4 | Seagen Inc. (SGEN) | Option exercise (M): 8,333 @ $34.20 · Sale (S): 8,333 @ $131.05 · Option exercise (M): 8,333 (derivative) @ $0 | EDGAR |
| 2022-11-16 | 4 | Seagen Inc. (SGEN) | Option exercise (M): 1,301 @ $76.86 · Option exercise (M): 1,301 (derivative) @ $0 | EDGAR |
| 2022-09-01 | 4 | Seagen Inc. (SGEN) | Sale (S): 1,755 @ $154.41 · Sale (S): 1,893 @ $154.41 | EDGAR |
| 2022-08-17 | 4 | Seagen Inc. (SGEN) | Grant/award (A): 13,731 @ $0 · Sale (S): 922 @ $170.22 · Sale (S): 717 @ $170.22 | EDGAR |
| 2022-04-27 | 4 | Erasca, Inc. (ERAS) | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2022-04-22 | 4 | Seagen Inc. (SGEN) | Sale (S): 401 @ $144.32 | EDGAR |
| 2022-01-20 | 4 | Seagen Inc. (SGEN) | Grant/award (A): 5,915 @ $0 | EDGAR |
| 2021-12-22 | 4 | Seagen Inc. (SGEN) | Sale (S): 276 @ $149.85 | EDGAR |
| 2021-11-05 | 4 | Seagen Inc. (SGEN) | Option exercise (M): 1,617 @ $46.37 · Option exercise (M): 1,617 (derivative) @ $0 | EDGAR |
| 2021-11-03 | 4 | Seagen Inc. (SGEN) | Option exercise (M): 34,876 @ $35.95 · Sale (S): 2,080 @ $173 · Sale (S): 2,588 @ $174.20 · Sale (S): 753 @ $175.08 · Sale (S): 8,776 @ $177.29 · Sale (S): 14,457 @ $178.07 · +2 more | EDGAR |
| 2021-09-27 | 4 | Seagen Inc. (SGEN) | Grant/award (A): 160 @ $166.22 | EDGAR |
| 2021-09-02 | 4 | Seagen Inc. (SGEN) | Sale (S): 1,893 @ $167.52 · Sale (S): 1,755 @ $167.52 | EDGAR |
| 2021-08-18 | 4 | Seagen Inc. (SGEN) | Sale (S): 718 @ $154.55 · Grant/award (A): 9,246 @ $0 · Grant/award (A): 642 (derivative) @ $0 · Grant/award (A): 21,915 (derivative) @ $0 | EDGAR |
| 2021-05-13 | 4 | Seagen Inc. (SGEN) | Sale (S): 1,061 @ $140 | EDGAR |
| 2021-02-18 | 4 | Seagen Inc. (SGEN) | Option exercise (M): 539 @ $46.37 · Option exercise (M): 2,207 @ $45.30 · Option exercise (M): 2,100 @ $35.95 · Option exercise (M): 2,100 (derivative) @ $0 · Option exercise (M): 2,207 (derivative) @ $0 · Option exercise (M): 539 (derivative) @ $0 | EDGAR |
| 2021-01-15 | 4 | Seagen Inc. (SGEN) | Option exercise (M): 5,000 @ $35.95 · Sale (S): 5,000 @ $180 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2020-12-16 | 4 | Seagen Inc. (SGEN) | Option exercise (M): 5,000 @ $35.95 · Sale (S): 1,641 @ $193.72 · Sale (S): 600 @ $194.80 · Sale (S): 300 @ $196.03 · Sale (S): 1,522 @ $197.14 · Sale (S): 937 @ $198.17 · +3 more | EDGAR |
| 2020-09-23 | 4 | SEATTLE GENETICS INC /WA (SGEN) | Option exercise (M): 2,554 @ $39.15 · Option exercise (M): 7,400 @ $35.95 · Option exercise (M): 7,400 (derivative) @ $0 · Option exercise (M): 2,554 (derivative) @ $0 | EDGAR |
| 2020-09-16 | 4 | SEATTLE GENETICS INC /WA (SGEN) | Sale (S): 11,610 @ $170 | EDGAR |
| 2020-09-02 | 4 | SEATTLE GENETICS INC /WA (SGEN) | Sale (S): 1,755 @ $155.69 · Sale (S): 1,893 @ $155.69 | EDGAR |
| 2020-08-20 | 4 | SEATTLE GENETICS INC /WA (SGEN) | Sale (S): 6,846 @ $158.17 | EDGAR |
| 2020-08-17 | 4 | SEATTLE GENETICS INC /WA (SGEN) | Grant/award (A): 7,195 @ $0 · Grant/award (A): 636 (derivative) @ $0 · Grant/award (A): 17,205 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1241357 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs